Eosinophilic airway inflammation is common in subacute cough following acute upper respiratory tract infection
- PMID: 26969485
- DOI: 10.1111/resp.12748
Eosinophilic airway inflammation is common in subacute cough following acute upper respiratory tract infection
Abstract
Background and objective: Patients presenting with refractory postinfectious cough may respond to glucocorticosteroids but it is unclear whether airway eosinophilic inflammation exists in those patients. We aimed to determine the airway inflammation and causes of subacute cough following acute upper respiratory tract infection (AURTI).
Methods: One hundred and sixteen patients with persistent cough lasting 3-8 weeks after upper respiratory tract infection were evaluated with differential cell count in induced sputum, spirometry and methacholine bronchial challenge testing.
Results: In patients with subacute cough, sputum eosinophilia (median 8.5%,3.0-73.0%) was identified in 35 (33.6%) patients, 22 (18.5%) without bronchial hyperresponsiveness (BHR) were diagnosed as non-asthmatic eosinophilic bronchitis (NAEB), 13 (14.3%) of whom with BHR were diagnosed as cough variant asthma (CVA). Cough in patients with sputum eosinophilia improved after treatment with corticosteroids. Compared with postinfectious cough (PIC) and NAEB, CVA had significantly higher median eosinophil count in induced sputum (0.5% vs 7.5% vs 20.0%, P < 0.01). MMEF in CVA was significantly lower than PIC and NAEB (P < 0.05). The common causes of subacute cough following acute upper respiratory tract infection (AURTI) were PIC (37.8%), NAEB (18.5%), CVA (14.3%) and upper airway cough syndrome (UACS) (10.1%). Atopic cough (AC) (5.2%) and gastroesophageal reflux-related cough (GERC) (3.4%) were less common in subacute cough following AURTI, while 9 (7.8%) patients had unexplained cough.
Conclusion: Subacute cough following AURTI can be attributed to different entities, eosinophilic airway inflammation is common. Induced sputum should be considered when evaluating patients with subacute cough following acute upper respiratory tract infection.
Keywords: Cough; Eosinophilic inflammation; Etiology; Postinfectious cough; Upper airway infection.
© 2016 Asian Pacific Society of Respirology.
Similar articles
-
Increased S-nitrosothiol levels in nonasthmatic eosinophilic bronchitis compared with cough variant asthma.Int Arch Allergy Immunol. 2011;156(1):99-103. doi: 10.1159/000321919. Epub 2011 Mar 30. Int Arch Allergy Immunol. 2011. PMID: 21447965
-
Eosinophilic airway disorders associated with chronic cough.Pulm Pharmacol Ther. 2009 Apr;22(2):114-20. doi: 10.1016/j.pupt.2008.12.001. Epub 2008 Dec 16. Pulm Pharmacol Ther. 2009. PMID: 19121405 Review.
-
Comparison of airway inflammation characteristics detected by lower exhaled nitric oxide in cough variant asthma, non-asthmatic eosinophilic bronchitis, and classic asthma.J Asthma. 2025 May;62(5):807-816. doi: 10.1080/02770903.2024.2444319. Epub 2025 Jan 8. J Asthma. 2025. PMID: 39693523
-
Clinical features of eosinophilic bronchitis.Korean J Intern Med. 2002 Mar;17(1):31-7. doi: 10.3904/kjim.2002.17.1.31. Korean J Intern Med. 2002. PMID: 12014210 Free PMC article.
-
[Syndrom Corrao--cough variant asthma].Przegl Lek. 2006;63(12):1318-20. Przegl Lek. 2006. PMID: 17642148 Review. Polish.
Cited by
-
Common Cold - an Umbrella Term for Acute Infections of Nose, Throat, Larynx and Bronchi.Pneumologie. 2017 Apr;71(4):221-226. doi: 10.1055/s-0042-116112. Epub 2016 Dec 2. Pneumologie. 2017. PMID: 27912214 Free PMC article. Review.
-
Efficacy and safety of Zihua Wenfei granules in treatment of postinfectious cough (wind-cold invading lungs syndrome): study protocol for a randomized controlled trial.Trials. 2020 Jun 19;21(1):547. doi: 10.1186/s13063-020-04487-9. Trials. 2020. PMID: 32560739 Free PMC article.
-
Efficacy and Safety of Zihua Wenfei Zhisou Granule in Treatment of Postinfectious Cough: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial.Chin J Integr Med. 2025 Jan;31(1):3-10. doi: 10.1007/s11655-024-3918-y. Epub 2024 Nov 22. Chin J Integr Med. 2025. PMID: 39576445 Clinical Trial.
-
Integrating pharmacokinetics and network pharmacology to decipher the efficacy of Fufang Qinlan oral liquid on post infectious cough.J Tradit Complement Med. 2024 Apr 12;15(3):250-263. doi: 10.1016/j.jtcme.2024.04.006. eCollection 2025 May. J Tradit Complement Med. 2024. PMID: 40486282 Free PMC article.
-
Clinical Practice Guidelines for Diagnosis and Management of Cough-Chinese Thoracic Society (CTS) Asthma Consortium.J Thorac Dis. 2018 Nov;10(11):6314-6351. doi: 10.21037/jtd.2018.09.153. J Thorac Dis. 2018. PMID: 30622806 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical